Keywords: novo, nordisk, 1st-qtr, profit, rises, danish, insulin
Novo Nordisk's 1st-qtr 2007 profit rises 41%
Article | 14 May 2007
Danish insulin giant Novo Nordisk's first-quarter 2007 net profit rose 41% on the like, year-ago period to 1.71 billion Danish kroner ($312.4 million), on ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
